NASDAQ: TRAXFirst Tracks Biotherapeutics Inc Stock Ownership - Who owns First Tracks Biotherapeutics?
Insider buying vs selling
Have First Tracks Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| J. Anthony Ware | Director | 2026-09-02 | 39,265 | $5.74 | $225.38kBuy |
| J. Anthony Ware | Director | 2026-09-02 | 39,265 | $44.78 | $1.76MSell |
| Ecor1 Capital LLC | 10% Owner | 2026-04-20 | 4,705,575 | $13.81 | $65.00MSell |
TRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TRAX insiders and whales buy or sell their stock.
TRAX Shareholders
What type of owners hold First Tracks Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ecor1 Capital LLC | 22.05% | 7,880,094 | $285.89M | Insider |
| Daniel Faga | 1.39% | 496,684 | $18.02M | Insider |
| Paul F. Lizzul | 0.12% | 42,669 | $1.55M | Insider |
| John P. Schmid | 0.11% | 37,652 | $1.37M | Insider |
| Rita Jain | 0.05% | 19,194 | $696.36k | Insider |
| John A. Orwin | 0.05% | 17,995 | $652.86k | Insider |
| Benjamin Stone | 0.05% | 17,262 | $626.27k | Insider |
| Magda Marquet | 0.04% | 15,960 | $579.03k | Insider |
| J. Anthony Ware | 0.04% | 15,660 | $568.14k | Insider |
| Dennis M. Fenton | 0.03% | 10,995 | $398.90k | Insider |
TRAX vs Biotech Stocks
First Tracks Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.